Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.

Elizabeth A HahnStephanie L PughHien L LuAlyssa M VelaErin F GillespieElizabeth M NicholsJean L WrightShannon M MacDonaldOren CahlonCarole BaasLior Z BraunsteinL Christine FangGary M FreedmanRachel B JimenezChristy M KessleringMark V MishraRobert W MutterNisha OhriLane R RosenJames J UrbanicReshma JagsiSandra A MitchellJustin E BekelmanDavid Cellanull null

Published in: International journal of radiation oncology, biology, physics (2024)

For patients with nonmetastatic breast cancer receiving radiation in the RadComp PRCT, our findings demonstrate high reliability and validity for important PRO measures, supporting their psychometric strength and usefulness to reflect the effect of RT on health-related quality of life.

Keyphrases

patient reported outcomes
study protocol
lymph node
phase iii
randomized controlled trial
phase ii
neoadjuvant chemotherapy
anti inflammatory
young adults
rectal cancer